{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:29:35Z","timestamp":1793996975059,"version":"4.8.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jnha.2025.100652","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:58:42Z","timestamp":1755503922000},"page":"100652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity?"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6264-9388","authenticated-orcid":false,"given":"Konstantinos","family":"Prokopidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Suetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jnha.2025.100652_bib0005","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae167","article-title":"GLP-1 and the neurobiology of eating control: recent advances","volume":"166","author":"Jones","year":"2025","journal-title":"Endocrinology."},{"key":"10.1016\/j.jnha.2025.100652_bib0010","series-title":"Monitoring report: GLP-1 RA prescribing trends-december 2024 data","author":"Gratzl","year":"2025"},{"issue":"1","key":"10.1016\/j.jnha.2025.100652_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Network Open."},{"key":"10.1016\/j.jnha.2025.100652_bib0020","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13929","article-title":"Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: a systematic review and meta-analysis","author":"Berg","year":"2025","journal-title":"Obes Rev."},{"issue":"3","key":"10.1016\/j.jnha.2025.100652_bib0025","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/dom.15400","article-title":"Impact of weight loss and weight gain trajectories on body composition in a population at high risk of type 2 diabetes: a prospective cohort analysis","volume":"26","author":"Yates","year":"2024","journal-title":"Diabetes Obes Metab."},{"issue":"3","key":"10.1016\/j.jnha.2025.100652_bib0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"},{"issue":"9","key":"10.1016\/j.jnha.2025.100652_bib0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"10.1016\/j.jnha.2025.100652_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1185221","article-title":"Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management","volume":"14","author":"Wei","year":"2023","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.jnha.2025.100652_bib0045","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1152\/japplphysiol.00853.2006","article-title":"Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss","volume":"102","author":"Weiss","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jnha.2025.100652_bib0050","first-page":"1","article-title":"The impact of bariatric surgery on the muscle mass in patients with obesity: 2-year follow-up","author":"Mart\u00ednez","year":"2022","journal-title":"Obes Surg."},{"issue":"8","key":"10.1016\/j.jnha.2025.100652_bib0055","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s11695-020-04654-6","article-title":"Rate and determinants of excessive fat-free mass loss after bariatric surgery","volume":"30","author":"Nuijten","year":"2020","journal-title":"Obes Surg."},{"issue":"5","key":"10.1016\/j.jnha.2025.100652_bib0060","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MED.0b013e32832f5a79","article-title":"Behavior therapy for obesity: where are we now?","volume":"16","author":"Sarwer","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"7","key":"10.1016\/j.jnha.2025.100652_bib0065","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/oby.22493","article-title":"Weight cycling as a risk factor for low muscle mass and strength in a population of males and females with obesity","volume":"27","author":"Rossi","year":"2019","journal-title":"Obesity."},{"key":"10.1016\/j.jnha.2025.100652_bib0070","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-025-09963-8","article-title":"Weight cycling and its effects on muscle mass, sarcopenia and sarcopenic obesity","author":"Zamboni","year":"2025","journal-title":"Rev Endocr Metab Disord."},{"issue":"4","key":"10.1016\/j.jnha.2025.100652_bib0075","first-page":"51","article-title":"Association between sarcopenic obesity, type 2 diabetes, and hypertension in overweight and obese treatment-seeking adult women","volume":"5","author":"Kreidieh","year":"2018","journal-title":"J Cardiovasc Dev Dis."},{"issue":"6","key":"10.1016\/j.jnha.2025.100652_bib0080","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.31805","article-title":"Intrapatient changes in CT-based body composition after initiation of semaglutide (glucagon-like peptide-1 receptor agonist) therapy","volume":"223","author":"Nelson","year":"2024","journal-title":"Am J Roentgenol."},{"issue":"3","key":"10.1016\/j.jnha.2025.100652_bib0085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3945\/ajcn.110.004895","article-title":"Is lost lean mass from intentional weight loss recovered during weight regain in postmenopausal women?","volume":"94","author":"Beavers","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jnha.2025.100652_bib0090","first-page":"69","article-title":"Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial","author":"Jensen","year":"2024","journal-title":"EClinicalMedicine."},{"issue":"1","key":"10.1016\/j.jnha.2025.100652_bib0095","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13841","article-title":"Strategies for minimizing muscle loss during use of incretin\u2010mimetic drugs for treatment of obesity","volume":"26","author":"Mechanick","year":"2025","journal-title":"Obes Rev."},{"key":"10.1016\/j.jnha.2025.100652_bib0100","first-page":"8","article-title":"Effects of exercise training and dietary supplement on fat free mass and bone mass density during weight loss\u2013a systematic review and meta-analysis","volume":"11","author":"Roth","year":"2022","journal-title":"F1000Research."}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770725001770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770725001770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:29:37Z","timestamp":1760538577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770725001770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1279770725001770"],"URL":"https:\/\/doi.org\/10.1016\/j.jnha.2025.100652","relation":{},"ISSN":["1279-7707"],"issn-type":[{"value":"1279-7707","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity?","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnha.2025.100652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100652"}}